MedPath

Maintaining Oral Health With Bio-products

Not Applicable
Active, not recruiting
Conditions
Dental Caries
Dental Erosion
Interventions
Other: Mouth rinse 1
Other: Mouth rinse 2
Other: Mouth rinse 3
Other: Mouth rinse 8
Other: Mouth rinse 4
Other: Mouth rinse 5
Other: Mouth rinse 6
Other: Mouth rinse 7
Other: Mouth rinse 9
Registration Number
NCT04033263
Lead Sponsor
University of Bern
Brief Summary

This study will follow a randomised, double-blind, cross-over design. Participants will use mouth rinses containing plant extracts and/or fluoride, as well as a mouth rinse containing only water (placebo). They will use oral appliances containing sterilized enamel and dentine slabs, which will be later collected for analyses.

The cross-over design will allow participants to use all rinses, allowing for a comparison between the rinses within each individual.

Detailed Description

This study will be made in three in situ parts. Participants will wear an oral appliance containing sterilized enamel and dentine slabs. During this experimental phase, they will use the designated mouth rinse. After this period, the investigators will remove the enamel and dentine slabs, and will also collect salivary pellicle and any bacterial biofilm forming on the participant's teeth. Participants will also donate saliva for proteomic analysis (protein profile) to verify if there are any differences in proteins in saliva to proteins in the pellicle. Throughout the whole study, all participants will use standardized oral hygiene products.

The experimental mouth rinses contain plant extracts that could interact with salivary proteins and influence the salivary pellicle and oral biofilm, thus bringing positive results against tooth (enamel and dentine) demineralisation.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Participants will be healthy young adults of both sexes, with normal salivary flow, with no cavitated caries lesions, no gingivitis or periodontal disease, no severe erosive tooth wear, and no other serious general or oral conditions.
  • Participants will have signed an informed consent form.
Exclusion Criteria
  • Presenting oral diseases or conditions, such as untreated cavitated caries lesions, gingivitis or periodontitis, severe erosive tooth wear, etc.
  • Participants who are under orthodontic treatment (wearing braces),
  • Contraindications to the mouth rinses under study, e.g. known hypersensitivity or allergy to the investigational product,
  • Participants using drugs that cause hyposalivation,
  • Women who are pregnant or breast feeding,
  • Intention to become pregnant during the course of the study,
  • Individuals suffering from clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
  • Participation in another study with investigational drug within the 30 days preceding and during the present study,
  • Enrolment of the investigator, his/her family members, employees and other dependent persons,
  • Specific exclusions for the disease under study,
  • Specific concomitant therapy washout requirements prior to and/or during study participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Placebo mouth rinseMouth rinse 1Placebo: Deionized water (serving as negative control)
Elmex mouth rinseMouth rinse 2Commercial mouth rinse used as gold standard in erosion studies: elmex® Erosion Protection solution (which contains 800 ppm Sn2+, as SnCl2, and 500 ppm F-, as NaF and AmF)
Fluoride mouth rinseMouth rinse 3Fluoride solution similar to many other commercial mouth rinses containing sodium fluoride (NaF at 500 ppm F-)
Plant extract CMouth rinse 8Plant extract C
Plant extract AMouth rinse 4Plant Extract A
Plant extract A with fluorideMouth rinse 5Plant Extract A + Fluoride
Plant extract BMouth rinse 6Plant extract B
Plant extract B with fluorideMouth rinse 7Plant Extract B + Fluoride
Plant extract C with fluorideMouth rinse 9Plant Extract C + Fluoride
Primary Outcome Measures
NameTimeMethod
Dentine mineral lossEnd of the study arm, expected to be after 1 week of using the mouth rinse

Profilometry of dentine specimens (step height in µm)

Enamel mineral lossEnd of the study arm, expected to be after 1 week of using the mouth rinse

Hardness of enamel slabs (Knoop hardness)

Secondary Outcome Measures
NameTimeMethod
Identification of which proteins are present in the participants' salivary pellicleEnd of the study arm, expected to be after 1 week of using the mouth rinse

Proteomic analyses of the salivary pellicle (list of proteins present)

How many bacteria are adhered to the biofilmEnd of the study arm in part 3, expected to be after 1 day of using the mouth rinse

Measured after collecting the biofilm (bacteria quantity)

Identification of which proteins are present in the participants' salivaEnd of the study arm, expected to be after 1 week of using the mouth rinse

Proteomic analyses of the saliva (list of proteins present)

Thickness of the salivary pellicleEnd of the study arm, expected to be after 1 week of using the mouth rinse

Measured using TEM (mineralization measured in Delta Z)

pH of the participants' biofilmEnd of the study arm in part 3, expected to be after 1 day of using the mouth rinse

Measured in vivo after using the mouth rinses (pH)

Identification of the bacteria in the biofilmEnd of the study arm in part 3, expected to be after 1 day of using the mouth rinse

Measured after collecting the biofilm (list of bacterial species)

Trial Locations

Locations (1)

Univesity of Bern (Klinik für Zahnerhaltung, Präventiv- und Kinderzahnmedizin)

🇨🇭

Bern, BE, Switzerland

© Copyright 2025. All Rights Reserved by MedPath